LLLouise Larsson

Louise Larsson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Louise Larsson has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Phage-steering permits antibody-mediated clearance of E. coli K1 from the gut

    by Louise Larsson, Anouk Bertola, Nicolas Wenner, Jasmine Kaur, Sara Dion, Leonardo Lemos Rocha, Timothy Keys, Christoph Rutschmann, Kateryna Vershynina, Despoina Dimakou, et al.

    Escherichia coli (E. coli) strains expressing the capsule serotype K1 (E. coli K1) are a prevalent cause of neonatal sepsis and meningitis. The gut microbiota of healthy adults is a natural reservoir of E. coli K1, from which it can spread to extra-intestinal sites or be transmitted from mother to infant during birth. Accordingly, shifting gut colonization from potentially pathogenic E. coli strains to more benign strains could reduce the risk of disease. Here, we leverage selective pressures exerted by bacteriophage and mucosal antibodies to limit gut colonization by E. coli K1 and prevent its transmission. K1-specific bacteriophages (phages) rapidly drive a within-host evolution of capsule-less mutants with exposed surface O-antigens. These mutants become susceptible to vaccine-induced intestinal IgA targeting the bacterial O-antigen, allowing competitive exclusion by the probiotic strain E. coli Nissle. In a murine vertical transmission model, 77% of pups were protected from transmission of E. coli K1 when the mother was vaccinated and treated with phages, whereas E. coli K1 was detected in most pups by day 10 of life when the mother received vaccination or phage therapy alone. Although the high diversity of E. coli makes generalization challenging, combining vaccination with phage-steering represents a promising approach for further exploration in eliminating infectious reservoirs.


  • Open Access

    The intestinal environment potentiates bacteriophage adaptation in response to phenotypic resistance in Salmonella Typhimurium

    by Nicolas Wenner, Anouk Bertola, Louise Larsson, Andrea Rocker, Nahimi Amare Bekele, Chris Sauerbeck, Leonardo F. Lemos Rocha, Valentin Druelle, Marco Molari, Alexander Harms, et al.

    Heterogeneous gene expression enables the coexistence of virulent phages with populations of isogenic bacteria comprising both phenotypically phage-resistant and susceptible cells. However, the evolvability of phages and the fitness cost they impose on susceptible bacteria challenge the evolutionary stability of the coexistence. Understanding this dynamic is critical for predicting phage–bacteria coevolution with implications for phage therapy, where resistance hinders treatment success. To address this point, we built on the discovery that heterogeneously expressed alterations of the O-antigen (phase variation) enable phenotypic resistance in Salmonella Typhimurium ( S .Tm) against the T5-like phage 37 (Φ37). We observed that phase variation allowed prolonged phage–bacteria coexistence in liquid medium. In contrast, phase variation only delayed the fixation of genetically phage-resistant S .Tm mutants when the phage–bacteria interaction took place in the gut of infected mice. The emergence of evolved phages capable of infecting both phenotypically susceptible and resistant phase variants of wild-type S .Tm selected for genetically resistant S .Tm mutants. Experimental in vitro evolution in a viscous medium recapitulated the short-lived coexistence of phages with susceptible S .Tm observed in the gut. This demonstrates that conditions in the gut increase the evolvability of phages by potentiating the effect of mutations that increase the phage host range, thereby negating the protection conferred by phase variation.


  • Vaccine-enhanced competition permits rational bacterial strain replacement in the gut

    by Verena Lentsch, Aurore Woller, Andrea Rocker, Selma Aslani, Claudia Moresi, Niina Ruoho, Louise Larsson, Stefan A. Fattinger, Nicolas Wenner, Elisa Cappio Barazzone, et al.

    Colonization of the intestinal lumen precedes invasive infection for a wide range of enteropathogenic and opportunistic pathogenic bacteria. We show that combining oral vaccination with engineered or selected niche-competitor strains permits pathogen exclusion and strain replacement in the mouse gut lumen. This approach can be applied either prophylactically to prevent invasion of nontyphoidal Salmonella strains, or therapeutically to displace an established Escherichia coli. Both intact adaptive immunity and metabolic niche competition are necessary for efficient vaccine-enhanced competition. Our findings imply that mucosal antibodies have evolved to work in the context of gut microbial ecology by influencing the outcome of competition. This has broad implications for the elimination of pathogenic and antibiotic-resistant bacterial reservoirs and for rational microbiota engineering.


  • Open Access

    Diagnosing and engineering gut microbiomes

    by Elisa Cappio Barazzone, Médéric Diard, Isabelle Hug, Louise Larsson, Emma Slack

    The microbes, nutrients and toxins that we are exposed to can have a profound effect on the composition and function of the gut microbiome. Thousands of peer-reviewed publications link microbiome composition and function to health from the moment of birth, right through to centenarians, generating a tantalizing glimpse of what might be possible if we could intervene rationally. Nevertheless, there remain relatively few real-world examples where successful microbiome engineering leads to beneficial health effects. Here we aim to provide a framework for the progress needed to turn gut microbiome engineering from a trial-and-error approach to a rational medical intervention. The workflow starts with truly understanding and accurately diagnosing the problems that we are trying to fix, before moving on to developing technologies that can achieve the desired changes.


  • Open Access

    Phenotypic heterogeneity drives phage-bacteria coevolution in the intestinal tract

    by Nicolas Wenner, Anouk Bertola, Louise Larsson, Andrea Rocker, Nahimi Amare Bekele, Chris Sauerbeck, Leonardo F. Lemos Rocha, Valentin Druelle, Alexander Harms, Médéric Diard

    Phenotypic heterogeneity in bacteria can generate reversible resistance against various stressors, including predation by phages. This allows mixed populations of phenotypically resistant and sensitive bacteria to coexist with virulent phages. However, it remains unclear if these dynamics prevent the evolution of genetic resistance in bacteria and how they affect the evolution of phages. In this work, we focus on bistable alterations of the O-antigen (known as phase variation) in Salmonella Typhimurium ( S .Tm) to study how heterogeneous phenotypic resistance affects phage-bacteria coevolution. Our findings reveal that phase variation allows a stable coexistence of S .Tm with a virulent T5-like phage in vitro . This coexistence is nevertheless short-lived when S .Tm and the phage interact within the intestinal tract of mice. In this context, the phage evolves to also infect phenotypically resistant S .Tm cells, incidentally altering infectivity on other Salmonella serovars. In return, the broader host range of the evolved phages drives the evolution of genetic resistance in S .Tm, which results in phage extinction. This work demonstrates that phenotypic heterogeneity profoundly influences the antagonistic coevolution of phages and bacteria, with outcomes intricately tied to the ecological context.


  • Open Access

    Mental illness and socio-economic situation of women and men diagnosed with gambling disorder (GD) in Sweden - nationwide case-control study

    by Louise Larsson, Anders Håkansson

    The present study aimed to compare men and women with gambling disorder (GD) regarding presence of psychiatric comorbidity and socio-economic vulnerability, and to examine whether these factors appear before or after the gambling disorder. This is a retrospective case-control study, based on registers from The National Board of Health and Welfare and Statistics Sweden. A total of 3592 adults with GD were matched with two controls based on age and gender, including a total of 10776 individuals in the study. The study included psychiatric comorbidity through the presence of relevant diagnostic codes or pharmacological codes, and socio-economic vulnerability data through the presence of unemployment, social welfare payments and sickness/activity/rehabilitation compensation. Time between GD and psychiatric comorbidity/socio-economic vulnerability was calculated by subtracting dates between diagnoses/first incidence of socio-economic vulnerability factor and GD diagnosis. Women with GD were more likely to have a psychiatric comorbidity, compared to men. Overall, women were also more likely to receive their psychiatric diagnosis prior to GD diagnosis, while men were more likely to receive the diagnoses concurrently. Social welfare payments, and sickness support were more common among women, while there was no difference in unemployment between genders. Women were also more likely to receive sickness/activity/rehabilitation compensation prior to GD, than men who were more likely to receive these types of support after GD diagnosis. In conclusion, women appear to be at higher risk of psychiatric comorbidity and socio-economic vulnerability alongside GD. They are in general also more likely to receive have their psychiatric and psycho-social problems identified prior to GD, than men who are more likely to receive diagnoses concurrently.


  • Open Access

    Vaccine-enhanced competition permits rational bacterial strain replacement in the gut

    by Verena Lentsch, Aurore Woller, Andrea Rocker, Selma Aslani, Claudia Moresi, Niina Ruoho, Louise Larsson, Stefan A. Fattinger, Nicolas Wenner, Elisa Cappio Barazzone, et al.

    Widespread antimicrobial resistance generates an urgent need to develop better disease prophylaxis for intestinal bacterial pathogens. While the first phase of infection with any bacterial pathogen is typically colonization of the mucosal surfaces, current vaccine strategies typically target invasive stages of disease. Here we demonstrate the ability to specifically generate sterilizing immunity against Salmonella enterica subspecies enterica serovar Typhimurium (S.Tm) at the level of gut lumen colonization using a combination of oral vaccination and a rationally-designed niche competitor strain. This is based on the proven ability of specific secretory IgA to generate a fitness disadvantage for a targeted bacterium, allowing a non-targeted competitor to rapidly overtake its niche. By hugely decreasing the population size of an intestinal pathogen during the early stages of infection, this improves protection of gut tissue compared to standard licensed animal vaccines. We demonstrate that most effective protection is generated when the niche competitor is derived from the pathogen and therefore occupies an identical niche. However, as this is unrealistic in real-world infections, we further demonstrate that robust protection can also be generated with a more distantly related “probiotic” niche competitor from a distinct species. Interestingly, focusing prophylaxis on the gut lumen reveals an uncoupling of protective mechanisms required for protection in the gut and gut tissues and those required for protecting against colonization of the spleen and liver. Therefore, while there is still potential to improve this approach by adding systemic immune activation, we nevertheless believe this is a fundamental step forward in our ability to manipulate colonization of intestinal bacteria with potential application to a wide-range of entero-pathogens, as well as to manipulation of microbiota composition.